Access cutting-edge mild asthma treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access mild asthma specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related mild asthma treatment provided free
The purpose of this study is to compare the efficacy and safety of albuterol/budesonide to albuterol in changes in airway inflammation, asthma symptoms, and rescue therapy utilization in adults with mild asthma. Study details include: * The study duration will be up to 15 weeks. * The treatment duration will be 12 weeks. * The visit frequency will be once every 4 weeks, with 3 clinic visits and 2 video calls in total.
Sponsor: AstraZeneca
Check if you qualify for this mild asthma clinical trial in Phoenix, AZ
If you're searching for mild asthma treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced mild asthma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.